Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 16, 2025 • 12:00 PM ET

Date/Time Source News Release
08/13/2025 08:00 AM EDT GlobeNewswire Artelo Biosciences Provides Business Update and Reports Second Quarter 2025 Financial Results
08/11/2025 09:15 AM EDT GlobeNewswire Artelo Biosciences Receives Notice of Allowance from European Patent Office for the Patent Claims for the Intended Commercial Formulation of ART27.13
08/04/2025 07:30 AM EDT GlobeNewswire Artelo Biosciences Announces $9.475 Million At-the-Market Private Placement to Initiate Solana Treasury Strategy, Becoming First Publicly-Traded Pharmaceutical Company to Adopt SOL as a Core Reserve Asset
08/01/2025 07:45 AM EDT GlobeNewswire Artelo Biosciences Receives Favorable UK MHRA Guidance for a Phase 1 Trial of ART12.11, the Company's Proprietary CBD:TMP Cocrystal Being Developed for the Treatment of Anxiety and Depression
07/09/2025 07:50 AM EDT GlobeNewswire Artelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society Symposium
07/07/2025 07:45 AM EDT GlobeNewswire Artelo Biosciences Announces Positive Preclinical Efficacy with ART12.11 in Stress-Induced Depression Model
06/30/2025 07:45 AM EDT GlobeNewswire Artelo Biosciences Announces Positive First-in-Human Data for ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain
06/26/2025 08:00 AM EDT GlobeNewswire Artelo Biosciences Announces $1.425 Million At-the-Market Private Placement Financing
06/11/2025 08:30 AM EDT GlobeNewswire Artelo Biosciences Announces Reverse Stock Split
06/05/2025 09:00 AM EDT GlobeNewswire Artelo's Fatty Acid Binding Protein 5 Inhibitor, ART26.12, Compares Favorably to Naproxen in an Osteoarthritis Pain Study
Page

Additional News

As of August 16, 2025 • 12:00 PM ET

Date/Time Source News Release
08/13/2025 10:12 AM EDT SeekingAlpha Artelo Biosciences GAAP EPS of -$5.61
08/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, August 12th, 2025
08/12/2025 05:31 AM EDT US Earnings Reports Expected earnings - Artelo Biosciences Inc.
08/11/2025 01:30 PM EDT PRISM News Artelo Biosciences Secures European Patent Approval for ART27.13 Formulation
07/07/2025 09:45 AM EDT 24/7 Market News Market Headliners- July 7, 2025
06/30/2025 12:55 PM EDT 24/7 Market News Top Stocks to Watch June 30, 2025: High-Potential Plays in AI, Biotech, VTOL, and Entertainment
06/30/2025 11:34 AM EDT IBN Spotlights Artelo Biosciences Inc. (NASDAQ: ARTL) Sees Notable Increase in Monday Morning Market Activity
05/13/2025 08:21 AM EDT SeekingAlpha Artelo Biosciences GAAP EPS of -$0.72
05/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, May 12th, 2025
05/12/2025 05:30 AM EDT US Earnings Reports Expected earnings - Artelo Biosciences Inc.
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.